A recent study led by Duke University has identified an energy production deficiency in white blood cells of veterans suffering from Gulf War Illness (GWI), offering a potential breakthrough for objective diagnosis and improved treatment. GWI, which affects around 250,000 U.S. veterans, has historically been diagnosed based on self-reported symptoms, such as fatigue, indigestion, and memory problems. This lack of objective measures has posed challenges for doctors.
The study focuses on blood samples and identifies an energetic deficiency in white blood cells. While not serving as a standalone diagnostic test, these measurements can help assess treatment efficacy and track the response of white blood cells over the course of treatment, potentially providing a more effective way to alleviate symptoms.
Search Antibodies Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.
GWI appears to impair white blood cells' mitochondria, cellular structures responsible for generating energy from food. This energy is essential for various bodily processes and functions.
The research also investigated the role of environmental factors in GWI, finding that veterans exposed to pesticides and pyridostigmine bromide during their service were more likely to develop GWI. The cause of GWI remains unknown, but these findings offer a promising avenue for further research and treatment development.
Joel Meyer, lead author of the study published in PLOS ONE, stated that understanding the energetic deficiency could lead to more effective symptom relief for veterans with GWI.